Octagon Capital Advisors’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
Sell
-200,000
Closed -$4.2M 35
2021
Q3
$4.2M Hold
200,000
1.04% 22
2021
Q2
$3.94M Hold
200,000
0.82% 31
2021
Q1
$5.81M Buy
200,000
+124,773
+166% +$3.63M 2.19% 19
2020
Q4
$2.28M Buy
+75,227
New +$2.28M 0.79% 28